Insider Transactions Reported by 17 Insiders of ENANTA PHARMACEUTICALS INC

Symbol
ENTA on Nasdaq
Location
Watertown, MA

Insiders trading volume in the past year

ENANTA PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ph.D. Jay R. Luly President and CEO, Director $12,424,161 -$67,493 -0.54% 12 Feb 2026
Yat Sun Or Chief Scientific Officer $5,341,669 -$34,010 -0.63% 12 Feb 2026
Nathaniel S. Gardiner Chief Legal Officer $1,003,410 26 Feb 2024
Brendan Luu Chief Business Officer $593,284 -$19,837 -3.2% 12 Feb 2026
PAUL J. MELLETT Chief Fin. & Admin Officer $535,992 12 Feb 2025
Tara Lynn Kieffer Chief Product Strategy Officer $483,431 -$29,968 -5.8% 12 Feb 2026
Rottinghaus Scott T. Chief Medical Officer $359,869 -$11,356 -3.1% 12 Feb 2026
Nathalie Adda Sr. VP & Chief Medical Officer $319,036 01 Apr 2022
Harry R. Trout III Vice President, Finance (Principal Financial Officer) $232,632 -$13,017 -5.3% 05 Dec 2025
Kathleen S. Capps Executive Director of Accounting, Controller (Principal Accounting Officer) $119,204 -$7,486 -5.9% 05 Dec 2025
Matthew Paul Kowalsky Chief Legal Officer $51,171 12 Feb 2026
Lesley Russell Director 13 Mar 2025
Kristine Peterson Director 13 Mar 2025
Terry Vance Director 13 Mar 2025
Yujiro S. Hata Director 13 Mar 2025
MARK G. FOLETTA Director 13 Mar 2025
BRUCE L. A. CARTER Director 13 Mar 2025

Recent Insider Transactions by Companies or Individuals for ENANTA PHARMACEUTICALS INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.